Science
-
Research updates, February 13
Research updates for the week of February 13 include mitochondrial dysfunction in people with Long Covid, risk of Long Covid among pregnant people, and the U.S.’s failure to protect frontline workers.
-
Research updates, February 6
New studies published in the last week include “zombie fragments” from SARS-CoV-2, the burden of Covid-19 for BIPOC individuals, and a ME drug with promise for Long Covid.
-
Research updates, January 30
Research updates for the week of January 30 include news from NIH RECOVER’s observational studies, cognitive slowing among people with Long Covid, and health issues that arise in infants whose mothers have Covid-19.
-
Research updates, January 23
Research updates for the week of January 23 include issues in the blood proteins of people with Long Covid, a potential mechanism for neurological symptoms, and preventative measures for Covid-19.
-
Research updates, January 16
New research for the week of January 16 include a study examining viral persistence in people with Long Covid, the link between Epstein-Barr virus and Multiple Sclerosis, and a therapy used for chest pain that may have Long Covid applications.
-
New CDC data identify more than 5,000 Long Covid deaths, but tally is likely a significant undercount
Last week, the Centers for Disease Control and Prevention (CDC) released new data on deaths caused by Long Covid, reporting that more than 5,000 Americans have died from this disease since 2020. The CDC’s numbers most likely represent significant undercounts of Long Covid-related deaths, experts say, highlighting a need for better reporting standards and education…
-
What’s happening this week, January 9
A new study in Nature Communications confirms what so many people with post-exertional malaise (PEM) have been saying for decades: exercise can make us worse. Plus: research about Paxlovid and returning to work, an upcoming march in DC, an important NIH webinar.
-
Q&A: Eric Topol on Long Covid clinical trials, RECOVER funding, what he’s looking forward to in 2024
To kick off a new year at The Sick Times, we’re excited to share a conversation looking ahead at future Long Covid research between Betsy Ladyzhets and Dr. Eric Topol, founder and director of the Scripps Research Translational Institute. Throughout the last four years, Topol has been a well-regarded commenter on Covid-19 and Long Covid,…
-
What’s happening this week, January 2
Research and advocacy updates for the week of January 2 include new research about a drug candidate for Long Covid and ME, markers of brain injury, Paxlovid, and a Twitter campaign.
-
Q&A: Ziyad Al-Aly on why Long Covid has a higher burden than “Long Flu,” future research, and more
Last week, clinical epidemiologist Ziyad Al-Aly and his team at Washington University and the St. Louis Veterans Affairs (VA) health system published a new paper demonstrating that Covid-19 has a higher long-term health burden than the flu. Betsy Ladyzhets from The Sick Times talked to Al-Aly about his new paper and other areas of Long…
Follow Us
get the latest long covid news
Trending
Recent ARTICLES
Tags
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance